Recent Updates — AUUD

Auddia Inc. amended its senior unsecured bridge notes, increasing the maximum funding available to three early-stage AI operating companies controlled by Dr. Jeffrey Thramann. The new limits raise total capacity from approximately $1.4 million to $3.305 million: up to $420,000 for Thramann Holdings, $1.9 million for LT350, $900,000 for Influence Healthcare, and $85,000 for Voyex. These funds provide working capital while the pending merger with McCarthy Finney remains subject to stockholder approval. Auddia Inc. develops audio technology and digital media platforms.

Auddia Inc. cancelled its October 7 shareholder meeting because the proposed merger with Thramann Holdings failed to receive approval by a majority of outstanding common shares, despite receiving approximately 89% of votes cast. The company cited an inability to locate additional shareholders from the original record date and announced plans to reschedule the vote after issuing a comprehensive update on its AI infrastructure strategy.

Auddia Inc. adjourned its Special Meeting of Stockholders scheduled for September 23, 2026, to October 7, 2026, because preliminary votes were insufficient to approve the proposed Business Combination with Thramann Holdings. Approximately 88% of shares voted supported the merger, but the company fell short of the majority-of-outstanding-shares threshold required for approval. The adjournment allows time to solicit additional proxies from stockholders of record as of August 3, 2026. Auddia operates in the AI and audio technology industry, developing platforms for music promotion and radio engagement.